Synergistic effect of Wharton's jelly-derived mesenchymal stem cells and insulin on Schwann cell proliferation in Charcot-Marie-Tooth disease type 1A treatment

Charcot-Marie-Tooth disease type 1A (CMT1A) is a demyelinating disease caused by PMP22 duplication and an exceedingly rare hereditary peripheral neuropathy, with an incidence of 1 in 2500. Currently, no cure exists for CMT1A; however, various therapeutic approaches are under development. Considering...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Shin Ji Oh, Hyeongseop Kim, Sang Eon Park, Jeong Hee Kim, Yong Jun Kim, Suk-joo Choi, Soo-young Oh, Hong Bae Jeon, Jong Wook Chang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2024-12-01
Serie:	Neurobiology of Disease
Soggetti:	Charcot-Marie-Tooth disease type 1A Wharton's jelly-derived mesenchymal stem cell Mesenchymal stem cell Insulin Combination therapy Regenerative medicine
Accesso online:	http://www.sciencedirect.com/science/article/pii/S0969996124003279
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!